Nibourel O, Guihard S, Roumier C, Pottier Letter, Terre C, Paquet An excellent, Peyrouze P, Geffroy S, Quentin S, Alberdi Good, Abdelali RB, Renneville Good, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok MH. Copy-amount analysis identified the brand new prognostic ;31(3):555-564.
Mohamed Am, Balsat M, Koering C, Maucort-Boulch D, Boissel Letter, Payen-Homosexual L, Cheok Meters, Mortada H, Auboeuf D, Pinatel C, El-Hamri Yards, Tigaud I, Hayette S, Dumontet C, Cros Elizabeth, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet Yards, Ceraulo An effective, Mortreux F, Wattel Elizabeth. Leuk Res. 2017;-28.
Mishima Y, Paiva B, Shi J, Park J, Manier S, Takagi S, Massoud Meters, Perilla-Glen A, Aljawai Y, Huynh D, Roccaro Are, Sacco A, Capelletti Yards, Detappe A great, Alignani D, Anderson KC, Munshi NC, Excel F, Lohr JG, Ha G, Freeman SS, Van Allen EM, Adalsteinsson Virtual assistant, Michor F, San Miguel JF, Ghobrial I am. 2017;19(1):218-224.
Minnema MC, Kimby Elizabeth, DSa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis Age, Kremer S, Fitsiori A good, Simon L, Davi F, Lunn Yards, Castillo JJ, Patterson CJ, Ce Garff-Tavernier Meters, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Tip into medical diagnosis, treatment and response conditions having Yahoo-Neel disorder. Haematologica. 2017;102(1):43-51.
Micol JB, Pastore Good, Inoue D, Duployez N, Kim Elizabeth, Lee Sc, Durham BH, Chung Year, Cho H, Zhang XJ, Yoshimi A good, Krivtsov A great, Koche R, Solary Age, Sinha An excellent, Preudhomme C, Abdel-Wahab O. ASXL2 is important for haematopoiesis and you will will act as a good haploinsufficient tumour suppressor in leukemia. Nat Commun. 2017;8:15429.
Telephone Agent
Meunier Yards, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet Meters, Wang Y, Faure P, Szymanski G, Duployez N, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Park S. Reactive clean air kinds membership manage NF-kappaB activation because of the lower dose deferasirox into the erythroid progenitors regarding lower risk myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524.
Manier S, Salem KZ, Playground J, Landau Weil, Getz G, Ghobrial I will be. Genomic difficulty out-of several myeloma and its own systematic ramifications. Nat Rev Clin Oncol. 2017;14(2):100-113.
Manier S, Powers JT, Sacco An excellent, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta Yards, Shi J, Mishima Y, how does xmeeting work Roche-Lestienne C, Leleu X, Roccaro Am, Daley GQ, Ghobrial I am. Brand new LIN28B/let-eight axis are a manuscript therapeutic pathway from inside the several myeloma. Leukemia. 2017;31(4):853-860.
Manier S, Liu CJ, Avet-Loiseau H, Playground J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco An effective, Roccaro Was, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller E, Trippa L, Ghobrial I will be. Prognostic character from releasing exosomal miRNAs during the multiple myeloma. Bloodstream. 2017;129(17):2429-2436.
TET2 exon dos bypassing was another positive prognostic basis to own cytogenetically regular serious myelogenous leukemia (AML): TET2 exon 2 skipping during the AML
Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Playground J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brownish Le, Grey Letter, Bradner J, Whitesell L, Porco JA, Jr., Ghobrial I will be. Inhibiting the latest oncogenic interpretation program is an efficient healing approach in the numerous myeloma. Sci Transl Med. 2017;9(389).
Magnez R, Thiroux B, Taront S, Segaoula Z, Quesnel B, Thuru X. PD-1/PD-L1 binding knowledge playing with microscale thermophoresis. Sci Rep. 2017;7(1):17623.
Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe A great, Dumezy F, Feuillard J, Genevieve F, Guerin E, Guy J, Jouault H, Lepelley P, Maynadie Meters, Solly F, Ballon OW, Preudhomme C, Baruchel A good, Dombret H, Ifrah N, Bene MC. Prognostic worth of multicenter disperse cytometry matched up assessment out of restricted recurring state from inside the serious myeloblastic leukemia. Hematol Oncol. 2017.